MedTrace Logo

Interactive Alcohol Decision-Making Programs

NCT05398315 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 352

Last updated 2023-06-06

No results posted yet for this study

Summary

This project aims to develop a maximally effective, computer-delivered brief intervention (CDBI) for reducing heavy alcohol use. More specifically, the investigators will examine outcomes of different versions of a CDBI in which the presence/absence of empathic statements, the gender of the narrator, the presence/absence of a narrator backstory, and the use/non-use of motivational interviewing techniques are systematically manipulated using a factorial design. Participants (352 heavy drinkers) will be randomly assigned to 1 of 16 intervention conditions, representing all combinations of the 4 variables being manipulated. The investigators hypothesize that there will be significant main effects of all four factors being manipulated on (a) subjective reactions to the CDBI and (b) alcohol outcomes at 1-month follow-up

Conditions

  • Heavy Drinking

Interventions

BEHAVIORAL

Empathic Statements/Reflections

Presence of Empathic Statements

BEHAVIORAL

Narrator Backstory

Presence of a narrator backstory

BEHAVIORAL

Male Narrator

Presence of a male narrator

BEHAVIORAL

Female Narrator

Presence of a female narrator

BEHAVIORAL

MI Techniques

Presence of MI techniques

Sponsors & Collaborators

  • Wayne State University

    lead OTHER

Principal Investigators

  • Emily Grekin, PhD · Wayne State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2023-04-01
Completion
2023-04-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398315 on ClinicalTrials.gov